Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.4000
0.00 (0.00%)
Aug 10, 2026, 12:07 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 30.32 million as of August 10, 2026. Its market cap has decreased by -6.11% in one year.
Market Cap
30.32M
Enterprise Value
28.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 30.32M, a decrease of -65.97%. That is a compound annual growth rate of -18.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 30.32M | -26.61% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 42.10M |
| Microbix Biosystems | 39.95M |
| Sona Nanotech | 38.32M |
| Telescope Innovations | 34.76M |
| Medicenna Therapeutics | 34.61M |
| Resverlogix | 32.66M |
| Quantum BioPharma | 30.78M |
| Thiogenesis Therapeutics | 28.51M |